M. Díaz-Ropero

Immunology and Animal Science Department, Puleva Biotech SA, Granada, Spain

Health Outcomes Studied

• Enhanced Natural Killer Cell Tumoricidal Activity
• Increased IL-12 Levels
• Increased Stool Volume

Papers (7)

• 2020
  Effects of Lactobacillus fermentum CECT5716 Lc40 on infant growth and health: a randomised clinical trial in nursing women.10.3920/BM2019.0180
• 2015
  Lactobacillus fermentum CECT 5716 Reduces Staphylococcus Load in the Breastmilk of Lactating Mothers Suffering Breast Pain: A Randomized Controlled Trial.10.1089/bfm.2015.0070
• 2009
  Safety Assessment of Lactobacillus fermentum CECT5716, a probiotic strain isolated from human milk10.1017/S0022029909004014
• 2007
  Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination.10.1016/J.NUT.2007.01.004
• 2007
  Safety assessment of the human milk-isolated probiotic Lactobacillus salivarius CECT5713.10.3168/JDS.2006-685
• 2006
  Oral administration of two probiotic strains, Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711, enhances the intestinal function of healthy adults.10.1016/J.IJFOODMICRO.2005.08.019
• 2006
  Antimicrobial potential of four Lactobacillus strains isolated from breast milk10.1111/j.1365-2672.2006.02981.x